Evidence supports the use of primary HPV testing to accelerate the global elimination of cervical cancer, but such recommendations must be viewed in the context of the fragile healthcare systems and complex implementation challenges in low-income and lower-middle income countries.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
WHO. http://gco.iarc.fr/today/home (2020).
WHO. https://go.nature.com/46vBlJj (2020).
WHO. https://go.nature.com/3LFNOSK (2021).
Simms, K. T. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02600-4 (2023).
Hall, M. T. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02601-3 (2023).
Bouvard, V. et al. N. Engl. J. Med. 385, 1908–1918 (2021).
Ronco, G. et al. Lancet 383, 524–532 (2014); erratum: 386, 1446 (2015).
Hall, M. T. et al. Lancet Public Health 4, e19–e27 (2019).
Chan, K. K. L. et al. Int. J. Cancer 147, 1152–1162 (2020).
Vale, D. B. et al. PLoS ONE 16, e0251688 (2021).
Kelly, H. et al. eClinicalMedicine 53, 101645 (2022).
Arbyn, M., Smith, S. B., Temin, S., Sultana, F. & Castle, P. BMJ 363, k4823 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Vale, D.B., Teixeira, J.C. Implementing plans for global elimination of cervical cancer. Nat Med 29, 3004–3005 (2023). https://doi.org/10.1038/s41591-023-02577-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02577-0
